A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors

Recruiting now · Not applicable

Conditions studied: Sexual Dysfunction, Stem Cell Transplant Complications, Bone Marrow Transplant Complications

In brief

This research study is evaluating the efficacy of a novel self-administered digital application for improving sexual health outcomes, quality of life, and psychological distress in hematopoietic stem cell transplant survivors.

Key facts

Study ID

NCT06541002

Run by

Massachusetts General Hospital

People needed

300

Starts

2025-01-27

Expected to finish

2030-04-30

Last updated by the study team

2026-03-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients (> 18 years) who underwent autologous or allogeneic HCT > three months prior to study enrollment
• Screen positive for sexual health concerns causing distress based on the National Comprehensive Network (NCCN) survivorship guidelines screening questions

You may not qualify if…

• Patients who do not comprehend English or Spanish since SHIFT will only be available in these two languages for this efficacy trial.
• Patients with any major uncontrolled psychiatric disorder or other comorbid cognitive conditions, which the treating HCT clinician believes would prohibit the patients' capacity to provide informed consent and participate in study procedures.
• Patients with relapsed disease requiring treatment.

Where it is running

• Massachusetts General Hospital (MGH) — Boston, Massachusetts, United States (enrolling)
• University of Miami — Coral Gables, Florida, United States
• Fox Chase Cancer Center — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.